BIO-TECHNE Corp
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Minneapolis, MN
TECH chart
What traders are saying about $TECH
Latest postsBIO-TECHNE Corp news
- PATH or APP: Which AI-driven Tech Stock Should You Bet on?
Zacks Investment Research ·
- Dell Technologies vs. Marvell Technology: Which Tech Stock Is the Better Buy in 2026?
The Motley Fool ·
- Coherent vs. Arm Holdings: Which Tech Stock Offers More Upside Now?
Yahoo Finance ·
- Arm vs. Western Digital: Which Tech Stock Is the Better Buy in November?
The Motley Fool ·
- D.A. Davidson reiterates Buy on Tyler Tech stock with $460 target
Investing.com India ·
- GOOGL vs. MSFT: Which Big Tech Stock Has More Upside Ahead of Earnings, According to Analysts?
TipRanks ·
- Megaport Shares Jump 9.6% as AI Infrastructure Bet Lifts ASX Tech Stock Ahead of Quarterly Update This Week
International Business Times Australia ·
- Argus Downgrades Bio-Techne to Sell From Buy
marketscreener.com ·
- Apple vs. Taiwan Semiconductor: Which Tech Stock Is a Better Buy in 2026?
The Motley Fool ·
- Bio-Techne Corp (TECH) Stock Forecasts
Yahoo Finance ·
- 1 healthcare stock for long-term investors and 2 we ignore
Yahoo Finance ·
- PLTR vs. ACN: Which Leading Tech Stock Should You Consider?
Yahoo Finance UK ·
BIO-TECHNE Corp key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B |
| Net income | – | $73.4M | $168.1M | $285.3M |
| Diluted EPS | $1.16 | $0.46 | $1.05 | $1.76 |
| Total assets (year end) | – | $2.52B | $2.67B | $2.73B |
| Cash and equivalents (year end) | – | $172.9M | $177.5M | $130.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BIO-TECHNE Corp
- Ticker
- TECH (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Minneapolis, MN
- Incorporated in
- MN
- Fiscal year end
- June 30
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/
Frequently asked questions
What exchange is BIO-TECHNE Corp listed on?
BIO-TECHNE Corp trades on the Nasdaq under the ticker symbol TECH.
What industry is BIO-TECHNE Corp in?
BIO-TECHNE Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is BIO-TECHNE Corp headquartered?
BIO-TECHNE Corp's business address on file with the SEC is in Minneapolis, MN.
When does BIO-TECHNE Corp's fiscal year end?
BIO-TECHNE Corp's fiscal year ends on June 30.
How much revenue did BIO-TECHNE Corp report?
BIO-TECHNE Corp reported $1.22B in revenue for calendar year 2026, according to its SEC filings.